Gefurulimab and Generalized Myasthenia Gravis

Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis https://jamanetwork.com/journals/jama... Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy https://jamanetwork.com/journals/jama... Podcast was originally published on July 27, 2026. https://edhub.ama-assn.org/jn-learnin... --------------------------------------------------------------------------------- Follow JAMA Neurology Author Interviews on: Youtube:    • JAMA Neurology Author Interviews   Apple Podcasts: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/7y27rTo... Pocket Casts: https://pca.st/NL2D Your podcast app of choice: https://pod.link/1227001063 Website: https://jamanetwork.com/journals/jama... --------------------------------------------------------------------------------- For more from JAMA • https://www.jama.com •   / jamajournal   •   / jama_current   •   / jamanetwork   Follow the JAMA Network • https://www.jamanetwork.com • http://www.jamanetworkaudio.com •   / jamanetwork   •   / jamanetwork   •   / jamanetwork   •   / jamanetwork